Assay reproducibility in clinical studies of plasma miRNA

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Rice, Jonathan ^a   Roberts, Henry ^a   Burton, James ^a   Pan, Jianmin ^b   States, Vanessa ^a   Rai, Shesh N ^b   Galandiuk, Susan ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 142 3P; MICRORNA 21; MICRORNA 218; MICRORNA 27A; MICRORNA 374; MICRORNA 374 5P; MICRORNA 376C; MICRORNA 485 3P; MICRORNA 520D 5P; MICRORNA 523; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; COLORECTAL ADENOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROFLUIDIC ANALYSIS; PLASMA; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SYSTEMATIC REVIEW; BIOASSAY; BLOOD; GENE EXPRESSION PROFILING; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PHLEBOTOMY; STANDARDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; BIOMARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PHLEBOTOMY; REPRODUCIBILITY OF RESULTS; RNA;

EID: 84929484672     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121948     Document Type: Article

References (103)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. doi: 10. 1038/35888 PMID: 9486653.
2. Julia Winter SJ, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology. 2009; 11:228-34. doi: 10.1038/ncb0309-228 PMID: 19255566
3. Stefanie Sassen EM, Caldas C. MicroRNA-implications for cancer. Virchows Arch. 2008; 452:1-10. Epub 11-27-2007. doi: 10.1007/s00428-007-0532-2 PMID: 18040713
4. Aaron J. Schetter HO, Harris CC. The Role of microRNAs in Colorectal Cancer. Cancer J. 2012; 18 (3):244-52. Epub 05-01-2013. doi: 10.1097/PPO.0b013e318258b78f PMID: 22647361
5. Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS. MicroRNA dysregulation in colorectal cancer: a clinical perspective. British journal of cancer. 2011; 104(6):893-8. doi: 10.1038/bjc.2011.57 PMID: 21364594; PubMed Central PMCID: PMC3065287.
6. Cho WC. Great potential of miRNAs as predictive and prognostic markers for cancer. Expert review of molecular diagnostics. 2012; 12(4):315-8. doi: 10.1586/erm.12.21 PMID: 22616694.
7. Cho WC. Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis. Frontiers in genetics. 2011; 2:7. doi: 10.3389/fgene.2011.00007 PMID: 22303306; PubMed Central PMCID: PMC3268566.
8. Ichikawa M, Akiyama H. A combination of extraction reagent and DNA microarray that allows for the detection of global miRNA profiles from serum/plasma. Methods in molecular biology. 2013; 1024:247-53. doi: 10.1007/978-1-62703-453-1-20 PMID: 23719957.
9. Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. Journal of extracellular vesicles. 2014; 3(23743). doi: 10.3402/jev.v3.23743 PMID: 24683445; PubMed Central PMCID: PMC3968297.
10. Ganepola GA, Rutledge JR, Suman P, Yiengpruksawan A, Chang DH. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. World journal of gastrointestinal oncology. 2014; 6(1):22-33. doi: 10.4251/wjgo.v6.i1.22 PMID: 24578785; PubMed Central PMCID: PMC3936193.
11. Bhatnagar S, Chertkow H, Schipper HM, Yuan Z, Shetty V, Jenkins S, et al. Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma. Frontiers in molecular neuroscience. 2014; 7:2. doi: 10.3389/fnmol.2014.00002 PMID: 24550773; PubMed Central PMCID: PMC3912349.
12. Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, et al. Serum micro- RNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study. Anticancer research. 2014; 34(2):665-9. PMID: 24510997.
13. Tsukamoto O, Miura K, Mishima H, Abe S, Kaneuchi M, Higashijima A, et al. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma. Gynecologic oncology. 2014; 132(3):715-21. doi: 10.1016/j.ygyno.2014.01.029 PMID: 24491411.
14. Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Ravagnani F, Perrone F, et al. Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. British journal of cancer. 2014; 110(4):1001-7. doi: 10.1038/bjc.2013.819 PMID: 24423916; PubMed Central PMCID: PMC3929896.
15. Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2014; 32 (8):768-73. doi: 10.1200/JCO.2013.50.4357 PMID: 24419137.
16. Yu H, Jiang L, Sun C, Li Guo L, Lin M, Huang J, et al. Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer. Gene. 2014; 534(1):60-5. PMID: 24404590.
17. Teixeira AL, Ferreira M, Silva J, Gomes M, Dias F, Santos JI, et al. Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35 (5):4057-66. doi: 10.1007/s13277-013-1531-3 PMID: 24379138.
18. Achberger S, Aldrich W, Tubbs R, Crabb JW, Singh AD, Triozzi PL. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Molecular immunology. 2014; 58(2):182-6. doi: 10.1016/j.molimm.2013.11.018 PMID: 24370793.
19. Shapira I, Oswald M, Lovecchio J, Khalili H, Menzin A, Whyte J, et al. Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes. British journal of cancer. 2014; 110(4):976-83. doi: 10.1038/bjc.2013.795 PMID: 24366298; PubMed Central PMCID: PMC3929876.
20. Szabo DR, Luconi M, Szabo PM, Toth M, Szucs N, Horanyi J, et al. Analysis of circulating microRNAs in adrenocortical tumors. Laboratory investigation; a journal of technical methods and pathology. 2014; 94(3):331-9. doi: 10.1038/labinvest.2013.148 PMID: 24336071.
21. Lu J, Xu X, Liu X, Peng Y, Zhang B, Wang L, et al. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. British journal of cancer. 2014; 110(2):392-8. doi: 10. 1038/bjc.2013.751 PMID: 24327016; PubMed Central PMCID: PMC3899774.
22. Quackenbush JF, Cassidy PB, Pfeffer LM, Boucher KM, Hawkes JE, Pfeffer SR, et al. Isolation of circulating microRNAs from microvesicles found in human plasma. Methods in molecular biology. 2014; 1102:641-53. doi: 10.1007/978-1-62703-727-3-34 PMID: 24259003.
23. Li H, Ge Q, Guo L, Lu Z. Maternal plasma miRNAs expression in preeclamptic pregnancies. BioMed research international. 2013; 2013:970265. doi: 10.1155/2013/970265 PMID: 24195082; PubMed Central PMCID: PMC3781840.
24. Roncarati R, Viviani Anselmi C, Losi MA, Papa L, Cavarretta E, Da Costa Martins P, et al. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2014; 63(9):920-7. doi: 10.1016/j.jacc.2013.09.041 PMID: 24161319.
25. Aushev VN, Zborovskaya IB, Laktionov KK, Girard N, Cros MP, Herceg Z, et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma. PloS one. 2013; 8(10):e78649. doi: 10.1371/journal.pone.0078649 PMID: 24130905; PubMed Central PMCID: PMC3793941.
26. Kishimoto T, Eguchi H, Nagano H, Kobayashi S, Akita H, Hama N, et al. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer. Cancer science. 2013; 104(12):1626-31. doi: 10.1111/cas. 12300 PMID: 24118467.
27. Tian Q, Jia J, Ling S, Liu Y, Yang S, Shao Z. A causal role for circulating miR-34b in osteosarcoma. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014; 40(1):67-72. doi: 10.1016/j.ejso.2013.08.024 PMID: 24063968.
28. Xiao B, Wang Y, Li W, Baker M, Guo J, Corbet K, et al. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. Blood. 2013; 122(19):3365-75. doi: 10.1182/blood- 2013-06-510586 PMID: 24041574; PubMed Central PMCID: PMC3821726.
29. Rong Y, Bao W, Shan Z, Liu J, Yu X, Xia S, et al. Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus. PloS one. 2013; 8(9):e73272. doi: 10.1371/ journal.pone.0073272 PMID: 24023848; PubMed Central PMCID: PMC3759444.
30. Garcia R, Villar AV, Cobo M, Llano M, Martin-Duran R, Hurle MA, et al. Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis. Journal of the American Heart Association. 2013; 2(4):e000211. doi: 10. 1161/JAHA.113.000211 PMID: 23948643; PubMed Central PMCID: PMC3828793.
31. Cheng HH, Mitchell PS, Kroh EM, Dowell AE, Chery L, Siddiqui J, et al. Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. PloS one. 2013; 8(7):e69239. doi: 10.1371/journal.pone.0069239 PMID: 23935962; PubMed Central PMCID: PMC3728349.
32. Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, et al. Circulating miRNA biomarkers for Alzheimer's disease. PloS one. 2013; 8(7):e69807. doi: 10.1371/journal.pone.0069807 PMID: 23922807; PubMed Central PMCID: PMC3726785.
33. Benson EA, Skaar TC. Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223. Drug metabolism and disposition: the biological fate of chemicals. 2013; 41(10):1778-81. doi: 10.1124/dmd.113.052357 PMID: 23886700; PubMed Central PMCID: PMC3781369.
34. Murata K, Furu M, Yoshitomi H, Ishikawa M, Shibuya H, Hashimoto M, et al. Comprehensive micro- RNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis. PloS one. 2013; 8(7):e69118. doi: 10.1371/journal.pone.0069118 PMID: 23874885; PubMed Central PMCID: PMC3715465.
35. Zheng W, Di Y, Liu Y, Huang G, Zheng Y, Zhang Y, et al. Development and application of a novel reverse transcription real-time PCR method for miR-499 quantification. Clinical biochemistry. 2013; 46 (15):1566-71. doi: 10.1016/j.clinbiochem.2013.06.024 PMID: 23872321.
36. Leuenberger N, Schumacher YO, Pradervand S, Sander T, Saugy M, Pottgiesser T. Circulating microRNAs as biomarkers for detection of autologous blood transfusion. PloS one. 2013; 8(6): e66309. doi: 10.1371/journal.pone.0066309 PMID: 23840438; PubMed Central PMCID: PMC3688786.
37. Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PloS one. 2013; 8(6):e64795. doi: 10. 1371/journal.pone.0064795 PMID: 23762257; PubMed Central PMCID: PMC3676411.
38. Marfella R, Di Filippo C, Potenza N, Sardu C, Rizzo MR, Siniscalchi M, et al. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. nonresponders. European journal of heart failure. 2013; 15(11):1277-88. doi: 10.1093/eurjhf/hft088 PMID: 23736534.
39. Du J, Cao X, Zou L, Chen Y, Guo J, Chen Z, et al. MicroRNA-21 and risk of severe acute kidney injury and poor outcomes after adult cardiac surgery. PloS one. 2013; 8(5):e63390. doi: 10.1371/journal. pone.0063390 PMID: 23717419; PubMed Central PMCID: PMC3662667.
40. Ellis KL, Cameron VA, Troughton RW, Frampton CM, Ellmers LJ, Richards AM. Circulating micro- RNAs as candidate markers to distinguish heart failure in breathless patients. European journal of heart failure. 2013; 15(10):1138-47. doi: 10.1093/eurjhf/hft078 PMID: 23696613.
41. Gourzones C, Ferrand FR, Amiel C, Verillaud B, Barat A, Guerin M, et al. Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients-evidence of non-exosomal transport. Virology journal. 2013; 10:119. doi: 10.1186/1743-422X-10-119 PMID: 23590857; PubMed Central PMCID: PMC3685608.
42. Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology. 2013; 58 (3):863-71. doi: 10.1002/hep.26296 PMID: 23390075; PubMed Central PMCID: PMC3664107.
43. Gorur A, Balci Fidanci S, Dogruer Unal N, Ayaz L, Akbayir S, Yildirim Yaroglu H, et al. Determination of plasma microRNA for early detection of gastric cancer. Molecular biology reports. 2013; 40 (3):2091-6. doi: 10.1007/s11033-012-2267-7 PMID: 23212612.
44. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, Santini G, et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. International journal of cardiology. 2013; 167(2):531-6. doi: 10.1016/j.ijcard.2012.01.075 PMID: 22330002.
45. Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, Linder J, et al. Plasma-based circulating Micro- RNA biomarkers for Parkinson's disease. Journal of Parkinson's disease. 2012; 2(4):321-31. doi: 10. 3233/JPD-012144 PMID: 23938262.
46. Ayaz L, Gorur A, Yaroglu HY, Ozcan C, Tamer L. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. Journal of cancer research and clinical oncology. 2013; 139(9):1499-506. doi: 10.1007/s00432-013-1469-2 PMID: 23817697.
47. Cai H, Yuan Y, Hao YF, Guo TK, Wei X, Zhang YM. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Medical oncology. 2013; 30(1):452. doi: 10.1007/ s12032-012-0452-0 PMID: 23307259.
48. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation. 2011; 124(18):1936-44. doi: 10.1161/ CIRCULATIONAHA.111.037572 PMID: 21969012.
49. Fan KL, Zhang HF, Shen J, Zhang Q, Li XL. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian heart journal. 2013; 65(1):12-6. doi: 10.1016/j.ihj. 2012.12.022 PMID: 23438607; PubMed Central PMCID: PMC3860780.
50. Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R, et al. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Journal of translational medicine. 2013; 11:31. doi: 10.1186/1479-5876-11-31 PMID: 23391324; PubMed Central PMCID: PMC3579719.
51. Freedman JE, Ercan B, Morin KM, Liu CT, Tamer L, Ayaz L, et al. The distribution of circulating micro- RNA and their relation to coronary disease. F1000Research. 2012; 1:50. doi: 10.12688/ f1000research.1-50.v1 PMID: 24358814; PubMed Central PMCID: PMC3752638.
52. Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, et al. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Annals of neurology. 2013; 73(6):729-40. doi: 10.1002/ana.23880 PMID: 23494648.
53. Ge Q, Li H, Yang Q, Lu J, Tu J, Bai Y, et al. Sequencing circulating miRNA in maternal plasma with modified library preparation. Clinica chimica acta; international journal of clinical chemistry. 2011; 412 (21-22):1989-94. doi: 10.1016/j.cca.2011.07.010 PMID: 21806976.
54. Gidlof O, Smith JG, Miyazu K, Gilje P, Spencer A, Blomquist S, et al. Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC cardiovascular disorders. 2013; 13:12. doi: 10.1186/1471-2261-13-12 PMID: 23448306; PubMed Central PMCID: PMC3598930.
55. Giraldez MD, Lozano JJ, Ramirez G, Hijona E, Bujanda L, Castells A, et al. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol. 2013; 11(6):681-8 e3. doi: 10.1016/j.cgh.2012.12.009 PMID: 23267864.
56. Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A, et al. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. British journal of cancer. 2013; 108(9):1822-9. doi: 10.1038/bjc.2013.148 PMID: 23579215; PubMed Central PMCID: PMC3658511.
57. Huang JJ, Yu J, Li JY, Liu YT, Zhong RQ. Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Medical oncology. 2012; 29(4):2402-8. doi: 10.1007/ s12032-012-0210-3 PMID: 22447484.
58. Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC genomics. 2013; 14:319. doi: 10.1186/1471-2164- 14-319 PMID: 23663360; PubMed Central PMCID: PMC3653748.
59. Jia SZ, Yang Y, Lang J, Sun P, Leng J. Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis. Human reproduction. 2013; 28(2):322-30. doi: 10.1093/humrep/ des413 PMID: 23203215; PubMed Central PMCID: PMC3733164.
60. Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, et al. A Plasma MicroRNA Panel for Detection of Colorectal Adenomas: A Step Toward More Precise Screening for Colorectal Cancer. Ann Surg. 2013; 258(3):400-8. doi: 10.1097/SLA.0b013e3182a15bcc PMID: 24022433.
61. Kawano Y, Iwata S, Kawada J, Gotoh K, Suzuki M, Torii Y, et al. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection. The Journal of infectious diseases. 2013; 208(5):771-9. doi: 10.1093/infdis/jit222 PMID: 23687223.
62. Kin K, Miyagawa S, Fukushima S, Shirakawa Y, Torikai K, Shimamura K, et al. Tissue- and plasmaspecific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. Journal of the American Heart Association. 2012; 1(5):e000745. doi: 10.1161/JAHA.112.000745 PMID: 23316282; PubMed Central PMCID: PMC3541608.
63. Kumar S, Keerthana R, Pazhanimuthu A, Perumal P. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients. Indian journal of biochemistry & biophysics. 2013; 50(3):210-4. PMID: 23898484.
64. Laterza OF, Scott MG, Garrett-Engele PW, Korenblat KM, Lockwood CM. Circulating miR-122 as a potential biomarker of liver disease. Biomarkers in medicine. 2013; 7(2):205-10. doi: 10.2217/bmm. 12.107 PMID: 23547815.
65. Leidner RS, Li L, Thompson CL. Dampening enthusiasm for circulating microRNA in breast cancer. PloS one. 2013; 8(3):e57841. doi: 10.1371/journal.pone.0057841 PMID: 23472110; PubMed Central PMCID: PMC3589476.
66. Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, et al. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer. Journal of surgical oncology. 2013; 108(2):89-92. doi: 10.1002/jso. 23358 PMID: 23733518.
67. Li YQ, Zhang MF, Wen HY, Hu CL, Liu R, Wei HY, et al. Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics. 2013; 68 (1):75-80. PMID: 23420161; PubMed Central PMCID: PMC3552456.
68. Luo X, Stock C, Burwinkel B, Brenner H. Identification and evaluation of plasma MicroRNAs for early detection of colorectal cancer. PloS one. 2013; 8(5):e62880. doi: 10.1371/journal.pone.0062880 PMID: 23690963; PubMed Central PMCID: PMC3653912.
69. Moldovan L, Batte K, Wang Y, Wisler J, Piper M. Analyzing the circulating microRNAs in exosomes/ extracellular vesicles from serum or plasma by qRT-PCR. Methods in molecular biology. 2013; 1024:129-45. doi: 10.1007/978-1-62703-453-1-10 PMID: 23719947; PubMed Central PMCID: PMC3923604.
70. Nair N, Kumar S, Gongora E, Gupta S. Circulating miRNA as novel markers for diastolic dysfunction. Molecular and cellular biochemistry. 2013; 376(1-2):33-40. doi: 10.1007/s11010-012-1546-x PMID: 23247724.
71. Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, et al. Circulating microRNAs as specific biomarkers for breast cancer detection. PloS one. 2013; 8(1):e53141. doi: 10.1371/journal.pone.0053141 PMID: 23301032; PubMed Central PMCID: PMC3536802.
72. Ouyang L, Liu P, Yang S, Ye S, Xu W, Liu X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Medical oncology. 2013; 30(1):340. doi: 10.1007/s12032-012-0340-7 PMID: 23269581.
73. Parikh VN, Chan SY. Analysis of microRNA niches: techniques to measure extracellular microRNA and intracellular microRNA in situ. Methods in molecular biology. 2013; 1024:157-72. doi: 10.1007/ 978-1-62703-453-1-12 PMID: 23719949; PubMed Central PMCID: PMC3753217.
74. Prats-Puig A, Ortega FJ, Mercader JM, Moreno-Navarrete JM, Moreno M, Bonet N, et al. Changes in circulating microRNAs are associated with childhood obesity. The Journal of clinical endocrinology and metabolism. 2013; 98(10):E1655-60. doi: 10.1210/jc.2013-1496 PMID: 23928666.
75. Sanfiorenzo C, Ilie MI, Belaid A, Barlesi F, Mouroux J, Marquette CH, et al. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PloS one. 2013; 8(1):e54596. doi: 10.1371/journal.pone.0054596 PMID: 23342174; PubMed Central PMCID: PMC3546982.
76. Shimizu C, Kim J, Stepanowsky P, Trinh C, Lau HD, Akers JC, et al. Differential expression of miR- 145 in children with Kawasaki disease. PloS one. 2013; 8(3):e58159. doi: 10.1371/journal.pone. 0058159 PMID: 23483985; PubMed Central PMCID: PMC3590129.
77. Soeda S, Ohyashiki JH, Ohtsuki K, Umezu T, Setoguchi Y, Ohyashiki K. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease. International journal of molecular medicine. 2013; 31(3):533-9. doi: 10.3892/ijmm.2013.1251 PMID: 23338559.
78. Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2013; 19(5):1213-24. doi: 10.1158/1078-0432.CCR-12-2726 PMID: 23362326; PubMed Central PMCID: PMC3596045.
79. Takahashi K, Yokota S, Tatsumi N, Fukami T, Yokoi T, Nakajima M. Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicology and applied pharmacology. 2013; 272(1):154-60. doi: 10.1016/j.taap.2013.05.018 PMID: 23726802.
80. Wang E, Nie Y, Zhao Q, Wang W, Huang J, Liao Z, et al. Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation. Journal of cardiothoracic surgery. 2013; 8:165. doi: 10. 1186/1749-8090-8-165 PMID: 23816326; PubMed Central PMCID: PMC3716980.
81. Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PloS one. 2013; 8(3): e58236. doi: 10.1371/journal.pone.0058236 PMID: 23469271; PubMed Central PMCID: PMC3587589.
82. Yamamoto M, Singh A, Sava F, Pui M, Tebbutt SJ, Carlsten C. MicroRNA expression in response to controlled exposure to diesel exhaust: attenuation by the antioxidant N-acetylcysteine in a randomized crossover study. Environmental health perspectives. 2013; 121(6):670-5. doi: 10.1289/ehp. 1205963 PMID: 23584289; PubMed Central PMCID: PMC3672916.
83. Zeng RC, Zhang W, Yan XQ, Ye ZQ, Chen ED, Huang DP, et al. Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer. Medical oncology. 2013; 30(1):477. doi: 10.1007/ s12032-013-0477-z PMID: 23389917.
84. Zhao J, Lei T, Xu C, Li H, Ma W, Yang Y, et al. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7- H3. Biochemical and biophysical research communications. 2013; 438(2):439-44. doi: 10.1016/j. bbrc.2013.07.095 PMID: 23916610.
85. Product Documentation: SAS Institute Inc.; 2014 [cited 2014 August 11, 2014]. Available from: http:// support.sas.com/documentation/93/.
86. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. The New England journal of medicine. 2012; 366(25):2345-57. doi: 10.1056/NEJMoa1114635 PMID: 22612596; PubMed Central PMCID: PMC3641846.
87. Rai SN RH, Yuan X, Pan J, Hamid T, Prabhu SD. Statistical Analysis of Repeated MicroRNA High Throughput Data with Application to Human Heart Failure: A Methodology Review. Open Access Medical Statistics, In Press. 2012. PMID: 24738042
88. Gonen M, editor Receiver Operating Characteristics (ROC) Curves. Thirty-first Annual SAS Users Group International Conference; 2006 Proceedings of the Thirty-first Annual SAS Users Group International Conference, Paper 210-31. Cary, NC: SAS Institute Inc..
89. Technologies L. TRIzol LS Reagent http://tools.lifetechnologies.com/content/sfs/manuals/trizol-ls- reagent.pdf: Life Technologies; 2010 [cited 2014].
90. Moret I, Sanchez-Izquierdo D, Iborra M, Tortosa L, Navarro-Puche A, Nos P, et al. Assessing an improved protocol for plasma microRNA extraction. PloS one. 2013; 8(12):e82753. doi: 10.1371/journal. pone.0082753 PMID: 24376572; PubMed Central PMCID: PMC3871541.
91. Technologies L. Protocol for Creating Custom RT and Preamplification Pools using TaqMan Micro- RNA Assays http://tools.lifetechnologies.com/content/sfs/manuals/cms-094060.pdf: 2013; 2013 [cited 2014].
92. Fleiss JL. Design and Analysis of Clinical Experiments. New York: John Wiley and Sons; 1986.
93. Dmitrienko A MG, Chuang-Stein C and Offen W. Analysis of Clinical Trials Using SAS: A practical Guide. Cary, NC, USA: SAS Institute Inc.; 2005.
94. Cambon AC BK, Brock GN, Cooper NGF, Wu D, and Rai SN. Classification of Clinical Outcomes Using High-throughput Informatics: Part 1- Nonparametric Method Reviews. Model Assisted Statistics and Applications. 2014. Epub In Press.
95. Cambon AC BK, Brock GN, Cooper NGF, Wu D, and Rai SN. Classification of Clinical Outcomes Using High-throughput Informatics: Part 2- Parametric Method Reviews. Model Assisted Statistics and Applications. 2014. Epub In Press.
96. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al. Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute. 2001; 93(14):1054-61. PMID: 11459866.
97. Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction: Oxford; 2003.
98. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009; 6(7):e1000097. doi: 10.1371/ journal.pmed.1000097 PMID: 19621072; PubMed Central PMCID: PMC2707599.
99. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(30):10513-8. doi: 10.1073/pnas. 0804549105 PMID: 18663219; PubMed Central PMCID: PMC2492472.
100. Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the MicroRNA spectrum between serum and plasma. PloS one. 2012; 7(7):e41561. doi: 10.1371/journal.pone.0041561 PMID: 22859996; PubMed Central PMCID: PMC3409228.
101. Wedge DC, Allwood JW, Dunn W, Vaughan AA, Simpson K, Brown M, et al. Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer. Analytical chemistry. 2011; 83(17):6689-97. doi: 10.1021/ac2012224 PMID: 21766834.
102. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, et al. Haemolysis during sample preparation alters microRNA content of plasma. PloS one. 2011; 6(9):e24145. doi: 10. 1371/journal.pone.0024145 PMID: 21909417; PubMed Central PMCID: PMC3164711.
103. Penny Whiting AWR, Reitsma JB, Bossuyt PMM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology. 2003; 3(25). Epub 11-10-2003. doi: 10.1186/1471-2288-3-25 PMID: 14606960